Home > > > > Report Detail

Global Diabetes Care Market (Insulin, OAD & GLP-1): Industry Analysis & Outlook (2019-2023)

Publisher Name :
Date: 01-Jun-2019
No. of pages: 120
Inquire Before Buying

Diabetes, referred to diabetes mellitus, is a group of metabolic disorders which abnormally affect the level of sugar (glucose) in blood. Diabetes can either be due to pancreas not producing enough insulin or irresponsiveness of cells of the body to insulin. Insulin is a hormone which regulates the metabolism of carbohydrates, fat and protein by absorbing glucose (sugar) from the blood into fat, liver and skeletal muscles.

Diabetic population is growing considerably all over the world. AAMEO region is experiencing the highest prevalence of diabetes compared to other parts of world. Increasing population in AAMEO countries is the key reason supporting the diabetic population. Every geographical region is witnessing growth in their respective diabetes care market due to this increasing prevalence of diabetes.

Global diabetes care market is majorly dominated by insulin segment. Insulin segment is broadly divided into modern insulin and human insulin. Modern insulin is growing at a faster rate than human insulin market. In terms of mode of action, insulin market is dominated by long acting insulin.

Geographically, North America holds the highest share in global diabetes care market due to its advanced healthcare system along with increasing diabetic population. However, in global insulin market, Europe holds the highest share.

Global diabetes market is highly consolidated in nature with three key players including Novo Nordisk; Sanofi; and Eli Lilly. These three companies are holding major shares in every regional diabetes market. Among all these companies, Novo Nordisk is leading in every region.

Global Diabetes Care Market (Insulin, OAD & GLP-1): Industry Analysis & Outlook (2019-2023)

Table of Contents

1. Overview
1.1 Diabetes
1.2 Symptoms of Diabetes
1.3 Diagnosis of Diabetes
1.4 Diabetes Management

2. Global Diabetes Market
2.1 Diabetes Population Forecast
2.2 Diabetes Care Market Value Forecast
2.3 Diabetes Care Market by Type
2.3.1 Global Insulin Market Value Forecast
2.3.2 Global OAD Market Value Forecast
2.3.3 Global GLP-1 Market Value Forecast
2.4 Diabetes Care Market by Region

3. Regional Diabetes Market
3.1 North America
3.1.1 North America Diabetes Care Market Value Forecast
3.1.2 North America Insulin Market Value Forecast
3.1.3 North America OAD Market Value Forecast
3.1.4 North America GLP-1 Market Value Forecast
3.2 Europe
3.2.1 Europe Diabetes Care Market Value Forecast
3.2.2 Europe Insulin Market Value Forecast
3.2.3 Europe OAD Market Value Forecast
3.2.4 Europe GLP-1 Market Value Forecast
3.3 Japan & Korea
3.3.1 Japan & Korea Diabetes Care Market Value Forecast
3.3.2 Japan & Korea Insulin Market Value Forecast
3.3.3 Japan & Korea OAD Market Value Forecast
3.3.4 Japan & Korea GLP-1 Market Value Forecast
3.4 AAMEO
3.4.1 AAMEO Diabetes Care Market Value Forecast
3.4.2 AAMEO Insulin Market Value Forecast
3.4.3 AAMEO OAD Market Value Forecast
3.4.4 AAMEO GLP-1 Market Value Forecast
3.5 China
3.5.1 China Diabetes Care Market Value Forecast
3.5.2 China Insulin Market Value Forecast
3.5.3 China OAD Market Value Forecast
3.5.4 China GLP-1 Market Value Forecast
3.6 Latin America
3.6.1 Latin America Diabetes Care Market Value Forecast
3.6.2 Latin America Insulin Market Value Forecast
3.6.3 Latin America OAD Market Value Forecast
3.6.4 Latin America GLP-1 Market Value Forecast

4. Insulin Market Analysis
4.1 Global Insulin Market Volume Forecast
4.2 Global Insulin Market Volume by Type
4.2.1 Global Long Acting Insulin Market Volume Forecast
4.2.2 Global Fast Acting Insulin Market Volume Forecast
4.2.3 Global Premix Insulin Market Volume Forecast
4.3 Global Insulin Market Volume by Region
4.3.1 Europe Insulin Market Volume Forecast
4.3.2 Europe Long Acting Insulin Market Volume Forecast
4.3.3 Europe Fast Acting Insulin Market Volume Forecast
4.3.4 Europe Premix Insulin Market Volume Forecast
4.3.5 North America Insulin Market Volume Forecast
4.3.6 North America Long Acting Insulin Market Volume Forecast
4.3.7 North America Fast Acting Insulin Market Volume Forecast
4.3.8 North America Premix Insulin Market Volume Forecast
4.3.9 AAMEO Insulin Market Volume Forecast
4.3.10 AAMEO Long Acting Insulin Market Volume Forecast
4.3.11 AAMEO Fast Acting Insulin Market Volume Forecast
4.3.12 AAMEO Premix Insulin Market Volume Forecast
4.3.13 China Insulin Market Volume Forecast
4.3.14 Latin America Insulin Market Volume Forecast
4.3.15 Latin America Long Acting Insulin Market Volume Forecast
4.3.16 Latin America Fast Acting Insulin Market Volume Forecast
4.3.17 Latin America Premix Insulin Market Volume Forecast
4.3.18 Japan & Korea Insulin Market Volume Forecast
4.3.19 Japan & Korea Long Acting Insulin Market Volume Forecast
4.3.20 Japan & Korea Fast Acting Insulin Market Volume Forecast
4.3.21 Japan & Korea Premix Insulin Market Volume Forecast

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Acceleration of Ageing Population
5.1.2 Increasing Obesity Rates
5.1.3 Longer Life Expectancy at Birth
5.1.4 Accelerating Economic Growth
5.1.5 Rising Healthcare Expenditure
5.2 Key Trends & Developments
5.2.1 Increasing Awareness
5.2.2 Rise of Digital Diabetes Care
5.3 Challenges
5.3.1 Stringent Legal Norms
5.3.2 High Cost and Alternative Treatments

6. Competitive Landscape
6.1 Global Diabetes Market Share by Company
6.2 Global Modern & New Generation Insulin Market Share by Company
6.3 North America Market
6.3.1 North America MI and NGI Market Share by Company
6.4 Europe Market
6.4.1 Europe MI & NGI Market Share by Company
6.4.2 Europe GLP-1 Market Share by Company
6.5 AAMEO Market
6.5.1 AAMEO MI & NGI Market Share by Company
6.5.2 AAMEO GLP-1 Market Share by Company
6.6 Japan & Korea Market
6.6.1 Japan Total Insulin Market Share by Company
6.6.2 J&K MI & NGI Market Share by Company
6.6.3 J&K GLP-1 Market Share by Company
6.7 China Market
6.7.1 China Total Insulin Market Share by Company
6.7.2 China GLP-1 Market Share by Company
6.8 Latin America Market
6.8.1 Latin America MI & NGI Market Share by Company
6.8.2 Latin America GLP-1 Market Share by Company

7. Company Profiles
7.1 Merck Group
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Novo Nordisk
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Eli Lilly and Company
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Sanofi S.A.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies

List of Charts

Type of Diabetes
Symptoms of Diabetes
Global Diabetes Population Forecast (2018-2023)
Global Diabetes Care Market Value Forecast (2014-2023)
Global Diabetes Care Market by Type (2018)
Global Insulin Market Value Forecast (2014-2023)
Global OAD Market Value Forecast (2014-2023)
Global GLP-1 Market Value Forecast (2014-2023)
Global Diabetes Care Market by Region (2018)
North America Diabetes Care Market Value Forecast (2014-2023)
North America Insulin Market Value Forecast (2014-2023)
North America OAD Market Value Forecast (2014-2023)
North America GLP-1 Market Value Forecast (2014-2023)
Europe Diabetes Care Market Value Forecast (2014-2023)
Europe Insulin Market Value Forecast (2014-2023)
Europe OAD Market Value Forecast (2014-2023)
Europe GLP-1 Market Value Forecast (2014-2023)
Japan & Korea Diabetes Care Market Value Forecast (2014-2023)
Japan & Korea Insulin Market Value Forecast (2014-2023)
Japan & Korea OAD Market Value Forecast (2014-2023)
Japan & Korea GLP-1 Market Value Forecast (2014-2023)
AAMEO Diabetes Care Market Value Forecast (2014-2023)
AAMEO Insulin Market Value Forecast (2014-2023)
AAMEO OAD Market Value Forecast (2014-2023)
AAMEO GLP-1 Market Value Forecast (2014-2023)
China Diabetes Care Market Value Forecast (2014-2023)
China Insulin Market Value Forecast (2014-2023)
China OAD Market Value Forecast (2014-2023)
China GLP-1 Market Value Forecast (2014-2023)
Latin America Diabetes Care Market Value Forecast (2014-2023)
Latin America Insulin Market Value Forecast (2014-2023)
Latin America OAD Market Value Forecast (2014-2023)
Latin America GLP-1 Market Value Forecast (2014-2023)
Global Insulin Market Volume Forecast (2014-2023)
Global Insulin Market Volume by Type (2018)
Global Long Acting Insulin Market Volume Forecast (2014-2023)
Global Fast Acting Insulin Market Volume Forecast (2014-2023)
Global Premix Insulin Market Volume Forecast (2014-2023)
Global Insulin Market Volume by Region (2018)
Europe Insulin Market Volume Forecast (2014-2023)
Europe Long Acting Insulin Market Volume Forecast (2014-2023)
Europe Fast Acting Insulin Market Volume Forecast (2014-2023)
Europe Premix Insulin Market Volume Forecast (2014-2023)
North America Insulin Market Volume Forecast (2014-2023)
North America Long Acting Insulin Market Volume Forecast (2014-2023)
North America Fast Acting Insulin Market Volume Forecast (2014-2023)
North America Premix Insulin Market Volume Forecast (2014-2023)
AAMEO Insulin Market Volume Forecast (2014-2023)
AAMEO Long Acting Insulin Market Volume Forecast (2014-2023)
AAMEO Fast Acting Insulin Market Volume Forecast (2014-2023)
AAMEO Premix Insulin Market Volume Forecast (2014-2023)
China Insulin Market Volume Forecast (2014-2023)
Latin America Insulin Market Volume Forecast (2014-2023)
Latin America Long Acting Insulin Market Volume Forecast (2014-2023)
Latin America Fast Acting Insulin Market Volume Forecast (2014-2023)
Latin America Premix Insulin Market Volume Forecast (2014-2023)
Japan & Korea Insulin Market Volume Forecast (2014-2023)
Japan & Korea Long Acting Insulin Market Volume Forecast (2014-2023)
Japan & Korea Fast Acting Insulin Market Volume Forecast (2014-2023)
Japan & Korea Premix Insulin Market Volume Forecast (2014-2023)
Global Ageing Population above 65 Years (2014-2018)
Global Obese Population (2014-2018)
Global Life Expectancy at Birth (2014-2018)
Global GDP Per Capita (2014-2018)
Global Healthcare Expenditure Per Capita (2014-2018)
Global Diabetes Market Share by Company (2018)
Global Modern Insulin (MI) & New Generation Insulin (NGI) Market Share by Company (2018)
North America MI and NGI Market Share by Company (2018)
Europe MI & NGI Market Share by Company (2018)
Europe GLP-1 Market Share by Company (2018)
AAMEO MI & NGI Market Share by Company (2018)
AAMEO GLP-1 Market Share by Company (2018)
Japan Total Insulin Market Share by Company (2018)
J&K MI & NGI Market Share by Company (2018)
J&K GLP-1 Market Share by Company (2018)
China Total Insulin Market Share by Company (2018)
China GLP-1 Market Share by Company (2018)
Latin America MI & NGI Market Share by Company (2018)
Latin America GLP-1 Market Share by Company (2018)
Merck Group Sales by Segment (2018)
Merck Group Net Sales and Net Income (2014-2018)
Novo Nordisk Sales by Segment (2018)
Novo Nordisk Net Sales and Net Income (2014-2018)
Eli Lilly and Company Revenue by Segments (2018)
Eli Lilly and Company Revenue and Net Income (2014-2018)
Eli Lilly and Company Research and Development Expenditure (2016-2018)
Sanofi S.A. Net Sales by Segment (2018)
Sanofi S.A. Net Sales and Net Income (2014-2018)
Sanofi S.A. R&D Expenditure (2016-2018)

  • Global Non-Invasive Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 79
    This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma. The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......
  • Global Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 106
    Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......
  • Global Blood Glucose Testing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 101
    Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes. Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter. A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......
  • Global Glucose Biosensors Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......
  • Global Artificial Pancreas Devices Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period. The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......
  • Global Blood Glucose Testing Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 130
    According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......
  • Global Lancing Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......
  • Global Non-Invasive Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......
  • Global Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs